Thorens

Thorens is a branded formulation used in the management of pain and inflammation.

It is prescribed for musculoskeletal conditions, post-operative pain, and other inflammatory disorders where effective analgesia is required.

The formulation provides reliable pain relief through its anti-inflammatory and analgesic properties, targeting the underlying inflammatory processes that contribute to pain.

It is particularly useful for patients who require consistent symptom control for conditions affecting joints, muscles, and soft tissues.

Thorens is designed for oral administration and is typically well tolerated when used according to prescribing guidelines.

As with all anti-inflammatory medications, the lowest effective dose for the shortest duration necessary should be used to minimise the risk of adverse effects.

Take tablets with or after food to reduce the risk of stomach irritation. Swallow whole with a glass of water.

The usual dosing frequency is every 8 hours as needed, though your prescriber may adjust this. Do not exceed the maximum daily dose. Avoid use on an empty stomach.

If pain persists beyond the expected treatment period, consult your doctor for reassessment.

Adults: 12.5 mg every 4-6 hours, or 25 mg every 8 hours. Maximum daily dose: 75 mg. Use the lowest effective dose for the shortest duration possible.

Elderly patients should start at the lower end of the dosing range. Dose reduction is required in mild to moderate hepatic or renal impairment.

Common (1 in 10 to 1 in 100): nausea, vomiting, abdominal pain, dyspepsia, and diarrhoea. Uncommon (1 in 100 to 1 in 1,000): headache, dizziness, insomnia, dry mouth, and flatulence.

Rare (less than 1 in 1,000): gastrointestinal bleeding or ulceration, hypersensitivity reactions including bronchospasm, renal impairment, and hepatic dysfunction.

Very rare: severe skin reactions such as Stevens-Johnson syndrome. The risk of GI complications increases with dose and duration of treatment.

Use with caution in patients with a history of gastrointestinal disease, including previous ulceration or bleeding. Avoid in the third trimester of pregnancy.

Concomitant use with other NSAIDs, aspirin, or anticoagulants increases the risk of bleeding. Cardiovascular risk may be increased with prolonged use at high doses.

Ensure adequate hydration to reduce the risk of renal complications.

Known allergy to dexketoprofen, aspirin, or other NSAIDs. Active peptic ulcer or gastrointestinal bleeding. Severe heart failure, severe hepatic or renal impairment. Third trimester of pregnancy.

History of asthma, urticaria, or allergic reactions triggered by NSAIDs or aspirin.